Thomas C. Hall, M.D., F.A.C.P.; D. Roberts; D. Kessell
This content is PDF only. Please click on the PDF icon to access.
Effective antileukemic agents are available for most forms of adult leukemia. Response frequency is low and time to remission, long. Progression of disease to death occurs in many patients before sequential therapeutic trials in search of an effective agent can be completed. Drug transport into cells, metabolism to active or inactive forms, the presence of target enzymes, and net effects on nucleic acid synthesis in the malignant cell may all be involved in the induction of a clinical remission. Isotopic micromethods have been developed in this laboratory for the measurement of the target enzymes for methotrexate (MTX) and 5-fluorouracil (FU),
Hall TC, Roberts D, Kessell D. Early Prediction of Clinical Responses to Anticancer Drugs.. Ann Intern Med. ;66:1064. doi: 10.7326/0003-4819-66-5-1064_2
Download citation file:
Published: Ann Intern Med. 1967;66(5):1064.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use